Multiplex autoantibody profiling for autoimmune diseases and cancer. April, 2, 2014. Profile antibodies to over 10,000 human proteins using Luminex xMAP™ technology. Jim Lazar, Ph.D. VP, Assay Development. OriGene Introduction. OTI Locations Rockville (HQTs/R&D) Seattle (Blue Heron)
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Multiplex autoantibody profiling for autoimmune diseases and cancer
April, 2, 2014
Profile antibodies to over 10,000 human proteins using Luminex xMAP™ technology
Jim Lazar, Ph.D.
VP, Assay Development
What is EarlyCDT–Lung?
EarlyCDT-Lung is a simple, physician-ordered, diagnostic blood test that measures the presence of autoantibodies to a panel of seven lung cancer-associated antigens.
Identification of many targets from a small number of samples
& Quantitative Evaluation
Large sample #s
Refine target list
Any of OriGene’s >10,000 purified proteins can be custom-coupled to Luminex beads
Protein-coupled Luminex Beads
Sample containing human IgG
Mix with Anti-human PE Conjugate
Read Signal in Luminex
Multiple profiling arrays can be mixed together and analyzed as a larger multiplex
Mix with beads, incubate
Total time – about 2.5 hours for 96 samples
Up to 100 results per well
Wash, add conj. & incubate
Read in Luminex
Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma.E Piura and B PiuraJ Oncol, Jan 2011; 2011: 982425.
Seromic profiling of ovarian and pancreatic cancer.
S. Gnjatic S, et al.
PNAS U S A. Mar 2010 16;107(11):5088-93.
A Distinct Repertoire of Autoantibodies in Hepatocellular Carcinoma Identified by Proteomic Analysis
François Le Naour, et al.
Mol. Cell. Proteomics, Mar 2002; 1: 197 - 203.
Multiple serological biomarkers for colorectal cancer detection.
CC Chan, et al.
Int J Cancer, Apr 2010; 126(7): 1683-90.